The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation
Open accessAbstract
Although a large proportion of patients with polycythemia vera (PV) harbor a valine-to-phenylalanine mutation at amino acid 617 (V617F) in the JAK2 signaling molecule, the stage of hematopoiesis at which the mutation arises is unknown. Here we isolated and characterized hematopoietic stem cells (HSC) and myeloid progenitors from 16 PV patient samples and 14 normal individuals, testing whether the JAK2 mutation could be found at the level of stem or progenitor cells and whether the JAK2 V617F-positive cells had altered differentiation potential. In all PV samples analyzed, there were increased numbers of cells with a HSC phenotype (CD34 + CD38 − CD90 + Lin − ) compared with normal samples. Hematopoietic progenitor assays demonstrated that the differentiation potential of PV was already skewed toward the erythroid lineage at the HSC level. The JAK2 V617F mutation was detectable within HSC and their progeny in PV. Moreover, the aberrant erythroid potential of PV HSC was potently inhibited with a JAK2 inhibitor, AG490.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Self-citationBonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
Baxter, E. J., Scott, L. M., Campbell, P. J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G. S., Bench, A. J., Boyd, E. M., Curtin, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71142-9 · Cited by 3,548
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
James, C., Ugo, V., Le Couédic, J.-P., Staerk, J., Delhommeau, F., Lacout, C., Garçon, L., Raslova, H., Berger, R., Bennaceur-Griscelli, A., et al. (2005) · Nature · doi:10.1038/nature03546 · Cited by 3,544
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
Kralovics, R., Passamonti, F., Buser, A. S., Teo, S.-S., Tiedt, R., Passweg, J. R., Tichelli, A., Cazzola, M., & Skoda, R. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051113 · Cited by 3,470
Levine, R. L., Wadleigh, M., Cools, J., Ebert, B. L., Wernig, G., Huntly, B. J. P., Boggon, T. J., Wlodarska, I., Clark, J. J., Moore, S., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.023 · Cited by 2,993
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617
Self-citationGranulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485
Morrison, S. J., & Weissman, I. L. (1994) · Immunity · doi:10.1016/1074-7613(94)90037-x · Cited by 1,115
Self-citationIsolation of a candidate human hematopoietic stem-cell population.
Baum, C. M., Weissman, I. L., Tsukamoto, A. S., Buckle, A. M., & Peault, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2804 · Cited by 1,086
Self-citationHuntly, B. J. P., Shigematsu, H., Deguchi, K., Lee, B. H., Mizuno, S., Duclos, N., Rowan, R., Amaral, S., Curley, D., Williams, I. R., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.015 · Cited by 697
Passegué, E., Jamieson, C. H. M., Ailles, L. E., & Weissman, I. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2034201100 · Cited by 686
Self-citationPolycythemia Vera: Stem-Cell and Probable Clonal Origin of the Disease
Adamson, J. W., Fialkow, P. J., Murphy, S., Prchal, J. F., & Steinmann, L. (1976) · New England Journal of Medicine · doi:10.1056/nejm197610212951702 · Cited by 640
Yamaoka, K., Saharinen, P., Pesu, M., Holt, V. E., Silvennoinen, O., & O'Shea, J. J. (2004) · Genome Biology · doi:10.1186/gb-2004-5-12-253 · Cited by 635
Prospective isolation of human clonogenic common myeloid progenitors
Manz, M. G., Miyamoto, T., Akashi, K., & Weissman, I. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172384399 · Cited by 534
Self-citationSteensma, D. P., Dewald, G. W., Lasho, T. L., Powell, H. L., McClure, R. F., Levine, R. L., Gilliland, D. G., & Tefferi, A. (2005) · Blood · doi:10.1182/blood-2005-03-1183 · Cited by 466
Miyamoto, T., Weissman, I. L., & Akashi, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7521 · Cited by 465
Self-citationJunB Deficiency Leads to a Myeloproliferative Disorder Arising from Hematopoietic Stem Cells
Passegué, E., Wagner, E. F., & Weissman, I. L. (2004) · Cell · doi:10.1016/j.cell.2004.10.010 · Cited by 440
Self-citationBone-Marrow Responses in Polycythemia Vera
(1974) · New England Journal of Medicine · doi:10.1056/nejm197406132902419 · Cited by 420
Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell
Fialkow, P., Faguet, G., Jacobson, R., Vaidya, K., & Murphy, S. (1981) · Blood · doi:10.1182/blood.v58.5.916.916 · Cited by 386
Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction.
Gilliland, D. G., Blanchard, K. L., Levy, J., Perrin, S., & Bunn, H. F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6848 · Cited by 253
Correa, P., Eskinazi, D., & Axelrad, A. (1994) · Blood · doi:10.1182/blood.v83.1.99.99 · Cited by 189
Stem Cell Research: Paths to Cancer Therapies and Regenerative Medicine
Weissman, I. L. (2005) · JAMA · doi:10.1001/jama.294.11.1359 · Cited by 170
Self-citationNegrin, R. S., Atkinson, K., Leemhuis, T., Hanania, E., Juttner, C., Tierney, K., Hu, W. W., Johnston, L. J., Shizuru, J. A., Stockerl-Goldstein, K. E., et al. (2000) · Biology of Blood and Marrow Transplantation · doi:10.1016/s1083-8791(00)70008-5 · Cited by 167
Self-citationUgo, V., Marzac, C., Teyssandier, I., Larbret, F., Lécluse, Y., Debili, N., Vainchenker, W., & Casadevall, N. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2003.11.003 · Cited by 166
Erythroid colony formation by polycythemia vera bone marrow in vitro. Dependence on erythropoietin.
Zanjani, E. D., Lutton, J. D., Hoffman, R., & Wasserman, L. R. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108706 · Cited by 161
Jak2 is involved in c-Myc induction by Bcr-Abl
Xie, S., Lin, H., Sun, T., & Arlinghaus, R. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205942 · Cited by 156
Dai, C., Krantz, S. B., Dessypris, E., Means, R. T., Horn, S., & Gilbert, H. S. (1992) · Blood · doi:10.1182/blood.v80.4.891.891 · Cited by 139
The chronic myeloproliferative disorders: Clonality and clinical heterogeneity
Spivak, J. L. (2004) · Seminars in Hematology · doi:10.1053/j.seminhematol.2004.02.011 · Cited by 127
Axelrad, A. A., Eskinazi, D., Correa, P. N., & Amato, D. (2000) · Blood · doi:10.1182/blood.v96.10.3310 · Cited by 117
On the molecular origins of the chronic myeloproliferative disorders: it all makes sense
Kaushansky, K. (2005) · Blood · doi:10.1182/blood-2005-03-1287 · Cited by 113
Chronic versus acute myelogenous leukemia
Jamieson, C. H. M., Weissman, I. L., & Passegue, E. A. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.12.005 · Cited by 89
Self-citationLasho, T. L., Mesa, R. A., Gilliland, D. G., & Tefferi, A. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05682.x · Cited by 60
Faderl, S. H., Harris, D., Van, Q., Kantarjian, H. M., Talpaz, M., & Estrov, Z. E. (2003) · Blood · doi:10.1182/blood-2002-06-1890 · Cited by 59
Kobayashi, S., Teramura, M., Hoshino, S., Motoji, T., Oshimi, K., & Mizoguchi, H. (1993) · British Journal of Haematology · doi:10.1111/j.1365-2141.1993.tb04688.x · Cited by 55
On the Molecular Origins of the Chronic Myeloproliferative Disorders: It All Makes Sense
Kaushansky, K. (2005) · Hematology · doi:10.1182/asheducation-2005.1.533 · Cited by 49
Dai, C., Krantz, S. B., Koury, S. T., et al. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb05065.x · Cited by 36
Péault, B., Weissman, I. L., Buckle, A., Tsukamoto, A. S., & Baum, C. M. (1993) · PubMed · Cited by 29
Self-citationDeSimone, J. (2004) · Seminars in Hematology · doi:10.1053/j.seminhematol.2004.08.001 · Cited by 28
Letter: Renal biopsy: oversophistication.
Gabriel, R. (1974) · PubMed · Cited by 16
Leukemia and Leukemic Stem Cells
Jamieson, C. H. M., Passegue, E. A., & Weissman, I. L. (2004) · Research and perspectives in neurosciences · doi:10.1007/978-3-642-18883-1_12 · Cited by 6
Self-citation
Cited by
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Mutation in TET2 in Myeloid Cancers
Delhommeau, F., Dupont, S., Valle, V. D., James, C., Trannoy, S., Massé, A., Kosmider, O., Le Couedic, J.-P., Robert, F., Alberdi, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810069 · Cited by 1,776
Yoder, M. C., Mead, L. E., Prater, D., Krier, T. R., Mroueh, K. N., Li, F., Krasich, R., Temm, C. J., Prchal, J. T., & Ingram, D. A. (2007) · Blood · doi:10.1182/blood-2006-08-043471 · Cited by 1,477
JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis
Scott, L. M., Tong, W., Levine, R. L., Scott, M. A., Beer, P. A., Stratton, M. R., Futreal, P. A., Erber, W. N., McMullin, M. F., Harrison, C. N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065202 · Cited by 1,276
MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients
Pardanani, A. D., Levine, R. L., Lasho, T., Pikman, Y., Mesa, R. A., Wadleigh, M., Steensma, D. P., Elliott, M. A., Wolanskyj, A. P., Hogan, W. J., et al. (2006) · Blood · doi:10.1182/blood-2006-04-018879 · Cited by 1,056
Metadata
- Authors
- Jamieson, C. H. M., Gotlib, J., Durocher, J. A., Chao, M. P., Mariappan, M. R., Lay, M., Jones, C., Zehnder, J. L., Lilleberg, S. L., & Weissman, I. L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2006-04-18
- Volume
- 103
- Issue
- 16
- Pages
- 6224-6229
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2029818817
- Cited by
- 286
- References
- 41
- FWCI
- 11.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.